Clinical Research Associate I
BeiGene
Summary
The CRA performs monitoring activities related to initiation, conduct (recruitment, quality data collection) and timely completion of Oncology and Hematology clinical trials within the country. The CRA is responsible for delivering data within timelines and required quality standards, responsible for adherence to monitoring procedures in accordance with GCP and ICH, local regulations and SOPs.
Job description
General Description
The CRA performs monitoring activities related to initiation, conduct (recruitment, quality data collection) and timely completion of Oncology and Hematology clinical trials within the country. The CRA is responsible for delivering data within timelines and required quality standards, responsible for adherence to monitoring procedures in accordance with GCP and ICH, local regulations and SOPs.
Essential Functions of the Job
- Conducts monitoring (pre-study, initiation, routine monitoring and closeout visit), if required
- Conducts co-monitoring visits, if required
- Ensures that study milestones for sites responsible are met as planned (i.e., study startup, recruitment, database analyses, closeout, etc.)
- Attends onboarding, disease indication and project specific training and general CRA training as required
- Documents monitoring activities appropriately following ICH-GCP and BeOne standards
- Conducts Quality Oversight Visits (QOV), as requested
- Completes monitoring visit/QOV reports timely
- Assists with investigator/site identification
- Assists site to prepare Ethics Committee submissions
- Facilitates clinical trial site contract and budget negotiation
- Manages site queries and communications
- Assists in managing clinical trials, if required
- Establishes regular lines of communication with sites and COMs
- Provides protocol and related study training to assigned sites
- Evaluates the quality and integrity of site practices – escalating quality issues as appropriate
- Manages site performance by tracking regulatory submissions, recruitment, case report form (CRF) completion, and data query resolution
- Collaborates with CRA Group/CRM to ensure recruitment plans and execute contingency plans, as needed
- Performs additional tasks as assigned
Computer Skills
- Efficient in Microsoft Word, Excel, PowerPoint, OneNote, and Outlook
- Familiar with industry EMR, CTMS, Site File Management, and data management systems
Other Qualifications
- At least 2 years of Clinical Research Coordinator experience in Oncology
- Understands clinical trial processes with a thorough knowledge of ICH and associated regulatory guidelines
- Excellent communication and interpersonal skills
- Excellent organizational skills and ability to prioritize and multi-task
- Fluent in English (writing and speaking)
Additional Experience
- Early Phase Preferred
- Hematology and Solid Tumor Experience Preferred
Travel
Up to 70% travel - multi regional
Education Required
- Bachelor's degree or above in life sciences, pharmacy, nursing or medical
- Understands clinical trial processes with a thorough knowledge of ICH and associated regulatory guidelines
Requirements
- At least 2 years of Clinical Research Coordinator experience in Oncology
- Bachelor's degree or above in life sciences, pharmacy, nursing or medical
- Thorough knowledge of ICH and associated regulatory guidelines
- Understanding of clinical trial processes
- Excellent communication and interpersonal skills
- Excellent organizational skills and ability to prioritize and multi-task
- Fluent in English (writing and speaking)
- Efficient in Microsoft Word, Excel, PowerPoint, OneNote, and Outlook
- Familiar with industry EMR, CTMS, Site File Management, and data management systems
- Early Phase experience preferred
- Hematology and Solid Tumor experience preferred
- Up to 70% travel - multi regional
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Annual bonus plan
- Discretionary equity awards
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.